All Posts by
The University of Florida’s Powell Gene Therapy Center has partnered with a biotechnology company to launch a gene therapy project aimed at developing potential treatments for Duchenne muscular dystrophy, the most common form of muscular dystrophy.
Federal agencies pursue world-renowned leaders when they seek expert advice. A recent search by the U.S. Food and Drug Administration for one such expert ended with a University of Florida College of Medicine pediatric researcher.
A biotechnology company has raised $30 million to advance gene therapy treatments developed at the University of Florida Powell Gene Therapy Center. The funding also will help UF Health researchers bring a novel form of gene therapy to patients with Pompe disease, a rare form of muscular dystrophy.
